Yale Rheumatology State of the Art Symposium: Pre-autoimmunity and the Prevention of Rheumatic Diseases
At the conclusion of this program, the participants should be able to:
- Discuss pre-autoimmunity and the prevention of rheumatic disease
- Use innovations and advancements in the field of rheumatoid disease
- Identify at-risk individuals
- Illustrate their knowledge on treatment options
- Employ approaches to future progress
Recent progress in our understanding of the development of autoimmunity suggests the opportunity of intervening in the prodromal phase of rheumatic diseases to prevent the future onset of clinically-apparent disease, such as arthritis or other disease manifestations.
This one-day international symposium will bring thought leaders together to review the conceptual basis and available clinical data for implementing preventive strategies in rheumatoid arthritis, systemic lupus erythematosus, and other autoimmune and rheumatic conditions. Topics will include the definition of at-risk individuals, interventions under study, and prospects for new approaches in basic scientific and clinical investigation, and for the design of therapeutic clinical trials.
The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Yale School of Medicine designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Coloroado TrustNed Calonge, MDPresident and CEO
University of Texas Southwestern Medical CenterBen Chong, MDAssistant Instructor
King's College LondonAndrew Cope, MD, PhDProfessor of Rheumatology
CUMC/Neurological Institute of New YorkPhilip De Jager, MD, PhDProfessor of Neurology
University of Colorado Hospital, Veterans Affairs Medical CenterKevin Deane, MD, PhDAssociate Professor of Medicine, Division of Rheumatology
University of Manitoba Arthritis CentreDr. Hani El-Gabalawy, MD, FRCPCProfessor of Medicine and Immunology
NIAMS Vasculitis Translational Research Program, National Institutes of HealthPeter C. Grayson, MD, MScTenure Track Investigator
Faculty of Pharmaceutical Sciences, University of British Columbia (UBC)Mark Harrison, PhDAssociate Professor
Oklahoma Medical Research FoundationJudith James, MD, PhDVice President of Clinical Affairs
UT Southwestern Medical CenterDavid Karp, MD, PhDProfessor and Chief, Rheumatic Disease Division
Penn State MS Hershey Medical CenterNancy Olsen, MDDepartment of Rheumatology
University of Rochester Medical CenterChristopher T. Ritchlin, MD, MPHProfessor of Medicine and Chief - Department of Medicine, Allergy/Immunology and Rheumatology (SMD)